{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:50:39Z","timestamp":1791204639803,"version":"4.2.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ijantimicag.2007.10.021","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T12:36:19Z","timestamp":1199709379000},"page":"287-289","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetics\/pharmacodynamics of levofloxacin 750mg once daily in young women with acute uncomplicated pyelonephritis"],"prefix":"10.1016","volume":"31","author":[{"given":"Lindsay","family":"Nicolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sitar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bryski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.10.021_bib1","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2165\/00003495-200363240-00008","article-title":"Levofloxacin: a review of its use in the treatment of bacterial infections in the United States","volume":"63","author":"Croom","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2007.10.021_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-4295(98)00160-5","article-title":"Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis","volume":"52","author":"Richard","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2007.10.021_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1586\/14787210.4.5.725","article-title":"Levofloxacin for the treatment of community-acquired pneumonia","volume":"5","author":"Lynch","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2007.10.021_bib4","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/AAC.44.10.2600-2603.2000","article-title":"Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers","volume":"44","author":"Lubasch","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.10.021_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11908-999-0044-0","article-title":"Pharmacologic basis for the treatment of pyelonephritis","volume":"1","author":"Beauchamp","year":"1999","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijantimicag.2007.10.021_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0924-8579(02)00105-X","article-title":"Correlation between pharmacokinetic\/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection","volume":"19","author":"Frimodt-Molloer","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.10.021_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"Critical review of fluoroquinolones: focus on respiratory infections","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2007.10.021_bib8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim\u2013sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907005493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907005493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T22:24:20Z","timestamp":1546381460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907005493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0924857907005493"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.10.021","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}